Roanoke Asset Management Corp NY Purchases 456 Shares of Danaher Co. (NYSE:DHR)

Roanoke Asset Management Corp NY increased its position in shares of Danaher Co. (NYSE:DHR) by 2.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,568 shares of the conglomerate’s stock after acquiring an additional 456 shares during the quarter. Danaher comprises approximately 1.5% of Roanoke Asset Management Corp NY’s investment portfolio, making the stock its 23rd biggest holding. Roanoke Asset Management Corp NY’s holdings in Danaher were worth $4,884,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Ashton Thomas Private Wealth LLC raised its holdings in Danaher by 44.5% during the 1st quarter. Ashton Thomas Private Wealth LLC now owns 4,970 shares of the conglomerate’s stock worth $1,241,000 after buying an additional 1,530 shares during the period. Norden Group LLC acquired a new stake in Danaher during the 1st quarter worth approximately $276,000. J.W. Cole Advisors Inc. raised its holdings in Danaher by 41.4% during the 1st quarter. J.W. Cole Advisors Inc. now owns 2,943 shares of the conglomerate’s stock worth $735,000 after buying an additional 861 shares during the period. Private Advisor Group LLC raised its holdings in Danaher by 5.2% during the 1st quarter. Private Advisor Group LLC now owns 42,467 shares of the conglomerate’s stock worth $10,605,000 after buying an additional 2,085 shares during the period. Finally, Diversify Advisory Services LLC acquired a new stake in Danaher during the 1st quarter worth approximately $401,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent research reports. Robert W. Baird lowered their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Raymond James lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Stephens reiterated an “overweight” rating and issued a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Bank of America lifted their price objective on shares of Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Finally, Evercore ISI lifted their price objective on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Insider Activity

In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 11.10% of the stock is currently owned by company insiders.

Danaher Trading Up 0.9 %

DHR stock opened at $247.82 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The company has a fifty day moving average price of $266.95 and a two-hundred day moving average price of $260.37. Danaher Co. has a one year low of $190.95 and a one year high of $281.70. The stock has a market cap of $178.99 billion, a price-to-earnings ratio of 47.29, a price-to-earnings-growth ratio of 4.45 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the previous year, the business posted $2.02 earnings per share. Equities analysts anticipate that Danaher Co. will post 7.51 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s payout ratio is presently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.